How Is Chronic Myeloid Leukemia Diagnosed?

This content has been reviewed and approved by

Hagop M. Kantarjian, MD
Chairman & Professor, Leukemia Department
MD Anderson Cancer Center
University of Texas
 

In addition to a complete medical history and physical examination, diagnostic procedures for chronic myeloid leukemia (CML) may include:

  • Additional blood tests and other evaluation procedures.
  • Bone marrow aspiration and/or biopsy. This is a procedure that involves taking a small amount of bone marrow fluid (aspiration) and/or solid bone marrow tissue (called a core biopsy), usually from the hip bones, to be examined for the number, size, and maturity of blood cells and/or abnormal cells. This will also be used to do chromosome studies to detect the Ph abnormality. This is the most important test to document CML.
This content was last modified on August 11, 2007 .
Latest Cancer News
“Scent” May Aid in Skin Cancer Diagnosis

August 21, 2008 — The concentration of certain molecules called volatile organic compounds (VOCs) given off by a cancer may ultimately contribute to accurate diagnosis of skin cancer. These results were recently presented at the 2008 annual American Chemical Society meeting.

Livial® Reduces Breast Cancer Risk but Increases Stroke Risk

August 21, 2008 — Livial® (tibolone), an agent used to reduce menopausal symptoms as well as bone loss, significantly reduces the risk of breast cancer and prevents bone loss and fractures in older postmenopausal women; however, it doubles the risk of stroke among postmenopausal women. These results were recently published in the New England Journal of Medicine.

Watchful Waiting Versus Radical Prostatectomy: 11-year Follow-up

August 21, 2008 — Researchers affiliated with the Scandinavian Prostatic Cancer Group Study Number 4 have reported the following: “Radical prostatectomy reduces prostate cancer mortality and risk of metastases with little or no further increase in benefit 10 or more years after surgery.” The details of the 3rd report of this randomized trial appeared in an early online publication in the Journal of the National Cancer Institute on August 11, 2008.

Select news items provided by Reuters Health